The Avastin (Bevacizumab) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Avastin (Bevacizumab) Global Market has witnessed robust growth in recent years. The market size has increased from $7,251.35 million in 2024 to $7,819.19 million in 2025. The compound annual growth rate (CAGR) during this period has been 7.8%.
The global market for Avastin (Bevacizumab) is projected to expand to $10,488.97 million by 2029, growing at a compound annual growth rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Avastin (Bevacizumab) Market Report and Uncover Key Trends Now!The key drivers in the avastin bevacizumab market are:
• The rise in global cancer prevalence
• Advancements in cancer detection methods
• Increased access to Avastin (bevacizumab) due to rising healthcare expenditure
• Continued growth and developments in medical technologies
The avastin (bevacizumab) market covered in this report is segmented –
1) By Dosage: 100 Mg, 400 Mg
2) By Application: Non Squamous Non-Small Cell Lung Cancer, Recurrent Glioblastoma, Cervical Cancer, Colorectal Cell Cancer, Ovarian Cancer, Proliferative Diabetic Retinopathy, Malignant Glioma, Neurofibromatosis, Pancreatic Cancer, Other Applications
3) By Distribution channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End User: Hospitals, Cancer Supportive Centers, Home Healthcare, Academic And Research Institutes, Other End Users
The key trends in the avastin bevacizumab market are:
• Growing integration of AI and automation is reshaping operational efficiency.
• Rising emphasis on sustainable and energy-efficient solutions is gaining traction.
• Enhanced focus on product customization is influencing manufacturing strategies.
• Strategic collaborations and partnerships are becoming more prevalent in the market.
Major players in the avastin bevacizumab market are:
• Roche Holding AG
The North America region leads the global Avastin (Bevacizumab) market according to the Global Market Report 2025.